MedTrace Logo

Prevalence and Trends of Antimicrobial Resistance of Helicobacter Pylori in Korea

NCT05247112 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2023-04-13

No results posted yet for this study

Summary

To assess antimicrobial resistance rates and minimal inhibitory concentrations in H. pylori isolated from patients with upper gastrointestinal disease with long-term period.

Conditions

  • Helicobacter Pylori Infection
  • Helicobacter Pylori Associated Gastrointestinal Disease
  • Helicobacter Pylori Infection, Susceptibility to
  • Helicobacter Pylori 23S rRNA Clarithromycin Resistance Mutation

Sponsors & Collaborators

  • Seoul National University Bundang Hospital

    lead OTHER

Principal Investigators

  • Nayoung Kim, M.D., Ph.D · Seoul National University Bundang Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-07-01
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05247112 on ClinicalTrials.gov